An update on diabetic kidney disease, oxidative stress and antioxidant agents

Leila Mahmoodnia ¹, Esmat Aghadavod ², Sara Beigrezaei ³, Mahmoud Rafieian-Kopaei ⁴ *

Cited by CrossRef: 30

1- Guo J, Li J, Wei H, Liang Z. Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-κB/Caspase-3 Pathways. DDDT. 2021;Volume 15:4339 [Crossref]

2- Pan L, Ye Y, Wo M, Bao D, Zhu F, Cheng M, Ni X, Fei X. Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy. Disease Markers. 2018;2018:1 [Crossref]

3- Patel V, Joharapurkar A, Kshirsagar S, Sutariya B, Patel M, Patel H, Pandey D, Bahekar R, Jain M. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus. WJD. 2018;9(6):80 [Crossref]

4- Wen W, Lin Y, Ti Z. Antidiabetic, Antihyperlipidemic, Antioxidant, Anti-inflammatory Activities of Ethanolic Seed Extract of Annona reticulata L. in Streptozotocin Induced Diabetic Rats. Front Endocrinol. 2019;10 [Crossref]

5- Ahmed Abd M, Ahmed Eid F. Possible Protective Role of Parsley Extract on the Diabetic Pregnant Rats and Their Fetuses. Pakistan J of Biological Sciences. 2017;20(11):552 [Crossref]

6- Ma N, Xu N, Yin D, Liu W, Wu M, Cheng X. Relationship between plasma total homocysteine and the severity of renal function in Chinese patients with type 2 diabetes mellitus aged ≥75 years. 2020;99(27):e20737 [Crossref]

7- Maheshwari R, Parmar G, Hinsu D, Seth A, Balaraman R. Novel therapeutic intervention of coenzyme Q10 and its combination with pioglitazone on the mRNA expression level of adipocytokines in diabetic rats. Life Sciences. 2020;258:118155 [Crossref]

8- Ojo O, Okesola M, Ekakitie L, Ajiboye B, Oyinloye B, Agboinghale P, Onikanni A. Gongronema latifolium Benth. leaf extract attenuates diabetes‐induced neuropathy via inhibition of cognitive, oxidative stress and inflammatory response . J Sci Food Agric. 2020;100(12):4504 [Crossref]

9- Liu M, Li J, Lv X, He Y. Bilirubin and its changes were negatively associated with diabetic kidney disease incidence and progression: A five-year's cohort study based on 5323 Chinese male diabetic patients. Journal of Diabetes and its Complications. 2018;32(11):1012 [Crossref]

10- Alabi T, Brooks N, Oguntibeju O. Leaf Extracts of Anchomanes difformis Ameliorated Kidney and Pancreatic Damage in Type 2 Diabetes. Plants. 2021;10(2):300 [Crossref]

11- Jia Q, Yang R, Liu X, Ma S, Wang L. Genistein attenuates renal fibrosis in streptozotocin‑induced diabetic rats. Mol Med Report. 2018; [Crossref]

12- Ninčević V, Omanović Kolarić T, Roguljić H, Kizivat T, Smolić M, Bilić Ćurčić I. Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes. IJMS. 2019;20(23):5831 [Crossref]

13- Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J, Karolczak K. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation. Oxidative Medicine and Cellular Longevity. 2021;2021:1 [Crossref]

14- Aly A, Hassan A, Makhlouf M, Alshammari M, Mohamed Naguib Abdel Hafez S, Refaie M, Bräse S, Nieger M, Ramadan M. Design and synthesis of hydrazinecarbothioamide sulfones as potential antihyperglycemic agents. Arch Pharm. 2021;354(5):2000336 [Crossref]

15- Ding Y, Li H, Li Y, Liu D, Zhang L, Wang T, Liu T, Ma L, De la Puerta R. Protective Effects of Grape Seed Proanthocyanidins on the Kidneys of Diabetic Rats through the Nrf2 Signalling Pathway. Evidence-Based Complementary and Alternative Medicine. 2020;2020:1 [Crossref]

16- Sim J, Kim J, Yang D. Beyond Lipid Signaling: Pleiotropic Effects of Diacylglycerol Kinases in Cellular Signaling. IJMS. 2020;21(18):6861 [Crossref]

17- Ahangarpour A, Oroojan A, Khorsandi L, Kouchak M, Badavi M. Hyperglycemia-induced oxidative stress in isolated proximal tubules of mouse: the in vitro effects of myricitrin and its solid lipid nanoparticle. Archives of Physiology and Biochemistry. 2021;127(5):422 [Crossref]

18- Septiana E, Rizka N, Yadi Y, Simanjuntak P. Antidiabetic Activity of Extract Combination of Orthosiphon aristatus and Oryza sativa L. var glutinosa. Borneo J Pharm. 2021;4(3):202 [Crossref]

19- Semenko A, Murdasov Y, Kirichenko S, Zhyliuk V, Ushakovа G. Influence of melatonin on the kidneys of rats with experimental diabetes mellitus type 2. Regul Mech Biosyst. 2020;11(3):384 [Crossref]

20- Zhang R, Lu M, Zhang S, Liu J. Renoprotective effects of Tilianin in diabetic rats through modulation of oxidative stress via Nrf2-Keap1 pathway and inflammation via TLR4/MAPK/NF-κB pathways. International Immunopharmacology. 2020;88:106967 [Crossref]

21- Almatroodi S, Alnuqaydan A, Babiker A, Almogbel M, Khan A, Husain Rahmani A. 6-Gingerol, a Bioactive Compound of Ginger Attenuates Renal Damage in Streptozotocin-Induced Diabetic Rats by Regulating the Oxidative Stress and Inflammation. Pharmaceutics. 2021;13(3):317 [Crossref]

22- Ma J, Yang Z, Jia S, Yang R. A systematic review of preclinical studies on the taurine role during diabetic nephropathy: focused on anti-oxidative, anti-inflammation, and anti-apoptotic effects. Toxicology Mechanisms and Methods. 2022;32(6):420 [Crossref]

23- Ahmed Abd M. Therapeutic Effects of Parsley Extract in Streptozotocin-induced Gestational Diabetic Rats. J of Biological Sciences. 2018;18(7):364 [Crossref]

24- Al-Hussaini H, Kilarkaje N. Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys. Toxicology and Applied Pharmacology. 2018;339:97 [Crossref]

25- Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash S. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & Pharmacotherapy. 2018;107:306 [Crossref]

26- Park S, Kang H, Jeon J, Kim M, Lee I. Recent advances in the pathogenesis of microvascular complications in diabetes. Arch Pharm Res. 2019;42(3):252 [Crossref]

27- Fakharzadeh S, Kalanaky S, Argani H, Dadashzadeh S, Torbati P, Nazaran M, Basiri A. Ameliorative effect of a nano chromium metal–organic framework on experimental diabetic chronic kidney disease. Drug Dev Res. 2021;82(3):393 [Crossref]

28- Wang E, Wang L, Ding R, Zhai M, Ge R, Zhou P, Wang T, Fang H, Wang J, Huang J. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy. Pharmacological Research. 2020;157:104831 [Crossref]